457 related articles for article (PubMed ID: 12663370)
1. Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages.
Luan Z; Chase AJ; Newby AC
Arterioscler Thromb Vasc Biol; 2003 May; 23(5):769-75. PubMed ID: 12663370
[TBL] [Abstract][Full Text] [Related]
2. Statins suppress THP-1 cell migration and secretion of matrix metalloproteinase 9 by inhibiting geranylgeranylation.
Wong B; Lumma WC; Smith AM; Sisko JT; Wright SD; Cai TQ
J Leukoc Biol; 2001 Jun; 69(6):959-62. PubMed ID: 11404382
[TBL] [Abstract][Full Text] [Related]
3. Pleiotropic effects of statins in atherosclerosis and diabetes.
Bellosta S; Ferri N; Arnaboldi L; Bernini F; Paoletti R; Corsini A
Diabetes Care; 2000 Apr; 23 Suppl 2():B72-8. PubMed ID: 10860194
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin inhibits MMP-9 secretion from human saphenous vein smooth muscle cells by inhibiting the RhoA/ROCK pathway and reducing MMP-9 mRNA levels.
Turner NA; O'Regan DJ; Ball SG; Porter KE
FASEB J; 2005 May; 19(7):804-6. PubMed ID: 15728660
[TBL] [Abstract][Full Text] [Related]
5. Simvastatin reduces MMP-3 level in interleukin 1beta stimulated human chondrocyte culture.
Lazzerini PE; Capecchi PL; Nerucci F; Fioravanti A; Chellini F; Piccini M; Bisogno S; Marcolongo R; Laghi Pasini F
Ann Rheum Dis; 2004 Jul; 63(7):867-9. PubMed ID: 15194586
[TBL] [Abstract][Full Text] [Related]
6. Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability.
Massaro M; Zampolli A; Scoditti E; Carluccio MA; Storelli C; Distante A; De Caterina R
Cardiovasc Res; 2010 May; 86(2):311-20. PubMed ID: 19946014
[TBL] [Abstract][Full Text] [Related]
7. The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity.
Staal A; Frith JC; French MH; Swartz J; Güngör T; Harrity TW; Tamasi J; Rogers MJ; Feyen JH
J Bone Miner Res; 2003 Jan; 18(1):88-96. PubMed ID: 12510809
[TBL] [Abstract][Full Text] [Related]
8. The effects of high glucose and atorvastatin on endothelial cell matrix production.
McGinn S; Poronnik P; Gallery ED; Pollock CA
Diabet Med; 2004 Oct; 21(10):1102-7. PubMed ID: 15384957
[TBL] [Abstract][Full Text] [Related]
9. Statins for the prevention of vein graft stenosis: a role for inhibition of matrix metalloproteinase-9.
Porter KE; Turner NA
Biochem Soc Trans; 2002 Apr; 30(2):120-6. PubMed ID: 12023838
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacies of five different statins on inhibition of human saphenous vein smooth muscle cell proliferation and invasion.
Turner NA; Midgley L; O'Regan DJ; Porter KE
J Cardiovasc Pharmacol; 2007 Oct; 50(4):458-61. PubMed ID: 18049315
[TBL] [Abstract][Full Text] [Related]
11. Protein isoprenylation regulates secretion of matrix metalloproteinase 1 from rheumatoid synovial fibroblasts: effects of statins and farnesyl and geranylgeranyl transferase inhibitors.
Abeles AM; Marjanovic N; Park J; Attur M; Chan ES; Al-Mussawir HE; Dave M; Fisher MC; Stuchin SA; Abramson SB; Pillinger MH
Arthritis Rheum; 2007 Sep; 56(9):2840-53. PubMed ID: 17763406
[TBL] [Abstract][Full Text] [Related]
12. Statins suppress MMP2 secretion via inactivation of RhoA/ROCK pathway in pulmonary vascular smooth muscles cells.
Li M; Li Z; Sun X
Eur J Pharmacol; 2008 Sep; 591(1-3):219-23. PubMed ID: 18619957
[TBL] [Abstract][Full Text] [Related]
13. Statins prevent pulsatile stretch-induced proliferation of human saphenous vein smooth muscle cells via inhibition of Rho/Rho-kinase pathway.
Kozai T; Eto M; Yang Z; Shimokawa H; Lüscher TF
Cardiovasc Res; 2005 Dec; 68(3):475-82. PubMed ID: 16098957
[TBL] [Abstract][Full Text] [Related]
14. Red wine polyphenolic compounds strongly inhibit pro-matrix metalloproteinase-2 expression and its activation in response to thrombin via direct inhibition of membrane type 1-matrix metalloproteinase in vascular smooth muscle cells.
Oak MH; El Bedoui J; Anglard P; Schini-Kerth VB
Circulation; 2004 Sep; 110(13):1861-7. PubMed ID: 15364805
[TBL] [Abstract][Full Text] [Related]
15. Effect of statins on the viability of macrophages and smooth muscle cells.
Croons V; De Meyer I; Houten SM; Martinet W; Bult H; Herman AG; De Meyer GR
J Cardiovasc Pharmacol; 2010 Mar; 55(3):269-75. PubMed ID: 20051876
[TBL] [Abstract][Full Text] [Related]
16. Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells.
Jantzen F; Könemann S; Wolff B; Barth S; Staudt A; Kroemer HK; Dahm JB; Felix SB; Landsberger M
J Physiol Pharmacol; 2007 Sep; 58(3):503-14. PubMed ID: 17928646
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor alpha induces human atrial myofibroblast proliferation, invasion and MMP-9 secretion: inhibition by simvastatin.
Porter KE; Turner NA; O'Regan DJ; Ball SG
Cardiovasc Res; 2004 Dec; 64(3):507-15. PubMed ID: 15537504
[TBL] [Abstract][Full Text] [Related]
18. Statins inhibit in vitro calcification of human vascular smooth muscle cells induced by inflammatory mediators.
Kizu A; Shioi A; Jono S; Koyama H; Okuno Y; Nishizawa Y
J Cell Biochem; 2004 Nov; 93(5):1011-9. PubMed ID: 15389884
[TBL] [Abstract][Full Text] [Related]
19. Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins.
Haendeler J; Hoffmann J; Zeiher AM; Dimmeler S
Circulation; 2004 Aug; 110(7):856-61. PubMed ID: 15289372
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of smooth muscle cell calcium mobilization and aortic ring contraction by lactone vastatins.
Escobales N; Crespo MJ; Altieri PI; Furilla RA
J Hypertens; 1996 Jan; 14(1):115-21. PubMed ID: 12013483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
